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Abstract: Due to the complexity and cumbersomeness of Gamma Knife (GK) manual forward 
planning, the quality of the resulting treatment plans heavily depends on the planners’ skill, 
experience and the amount of effort devoted to plan development. Hence, GK plan quality may 
vary significantly among institutions and planners, and even for a same planner at different 
cases. This is particularly a concern for challenging cases with complicated geometry, such as 
vestibular schwannoma cases. The purpose of this retrospective study is to investigate the plan 
quality and variation in the manually forward planned, clinically acceptable GK treatment plans 
of 22 previous vestibular schwannoma cases. Considering the impacts of different patient 
geometry and different trade-offs among the planning objectives in GK planning, it is difficult 
to objectively assess the plan quality across different cases. To reduce these confounding factors 
on plan quality assessment, we employed our recently developed multiresolution-level inverse 
planning algorithm to generate a golden plan for each case, which is expected to be on or close 
to the pareto surface with a similar trade-off as used in the manual plan. The plan quality of the 
manual plan is then quantified in terms of its deviation from the golden plan. A scoring criterion 
between 0-100 was designed to calculate a final score for each manual plan to simplify our 
analysis. Large quality variation was observed in these 22 cases, with two cases having a score 
lower than 75, three cases scoring between 80 and 85, two cases between 85 and 90, eight cases 
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between 90 and 95, and seven cases higher than 95. Inter- and intra- planner variability was 
also observed in our study. This large variation in GK manual planning deserves high attention, 
and merits further investigation on how to reduce the variation in GK treatment plan quality. 
Key words:  Gamma Knife radiosurgery, manual forward treatment planning, plan quality 
variation, vestibular schwannoma 
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1 INTRODUCTION 
Gamma Knife (GK) radiosurgery has emerged as an important and safe alternative to traditional 
neurosurgery for vestibular schwannoma1-3. The most advanced GK treatment units, i.e. PerfexionTM 
and IconTM (Elekta Instrument AB Stockholm, Stockholm, Sweden), focus 192 narrow 60Co beams 
on a single point. This design can eradicate tumor viability with submillimeter accuracy, while 
providing a very steep dose gradient to minimize damage to surrounding normal tissues in order to 
reduce risk of side effects and improve cochlear sparing.  
Manual forward planning is the current standard GK planning method, in which planners adjust 
the number and locations of the irradiation focal points, beam sizes, shapes and beam-on time in a 
trial-and-error schema to achieve a clinically acceptable treatment plan. Ideally, any location within 
the target volume is a potential beam isocenter. In addition, since the 192 sources are arranged on 
eight individual sectors that can be driven independently to one of four different states (i.e., 4, 8 or 
16 mm collimator sizes or be blocked), there are 65,536 (i.e. 48) available beam shapes to be used 
at each isocenter. With such large degrees of freedom involved in planning, manual forward 
planning is challenging and cumbersome, particularly for vestibular schwannoma cases due to the 
irregular-shaped target and its proximity to brainstem and cochlea4-9. It is impossible for planners 
to explore the whole solution space via manual forward planning to develop the best plan for each 
specific patient. The resulting plan quality hence heavily relies on planners’ skills, experiences, and 
available time to develop the plan, and can vary significantly from case to case, planner to planner 
and institution to institution.   
Although there have been studies comparing plan qualities between GK, CyberKnife (Accuray 
Incorporated company, Sunnyvale, CA) and linac-based radiosurgery10-18, there are few studies 
which focus on the plan quality and variation of GK radiosurgery itself. In this study, we aim to 
perform a retrospective study to investigate the plan quality and variation of our previous treated 
GK treatment plans that have been generated via manual forward planning for our previous 
vestibular schwannoma cases. There are two challenges that are encountered when attempting to 
assess the plan quality and variation of GK radiosurgery. First, the best plan quality that can be 
achieved for each patient is essentially determined by his or her specific geometry. For instance, 
due to the nature of GK radiosurgery, a target with an irregular shape is prone to inferior dose 
conformity compared to a target with a spherical shape. Hence, an equivalent dose conformity index 
achieved in a treatment plan doesn’t necessarily translate to the same plan quality for different 
patients. As previously mentioned, the large number of variables involved in GK planning makes it 
impossible for planners to explore the whole solution space via manual forward planning. Thus, we 
do not have a priori knowledge of the best plan quality that can be achieved for each specific patient 
geometry, which makes it difficult to quantify and compare the plan quality. Secondly, a trade-off 
among multiple planning objectives is often needed when all the planning objectives cannot be met 
at the same time. For instance, when a critical organ is very close to the target, physicians need to 
determine the priority between target coverage and organ sparing based on the health conditions of 
the particular patient. Another trade-off we often encounter in GK planning is between dose 
conformity and beam-on time. High dose conformity is often associated with small collimator sizes 
which are more flexible for beam shaping but prolongs the beam-on time. Different trade-offs 
adopted on the same case would result in different plan properties, which doesn’t necessarily mean 
different plan qualities.  
We have recently developed a multi-resolution-level (MRL) inverse planning approach for GK 
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radiosurgery, which provides a feasible solution to approach the intractable large-scale global 
optimization problem iteratively, and yields a pareto optimal plan or a plan close to the pareto 
surface19. In this study, we employed this MRL inverse planning approach to conquer the two 
aforementioned challenges to enable our investigation of the plan quality and variation of GK 
manual forward planning for the previous vestibular schwannoma treatment in our institution. In 
addition, a scoring mechanism was designed to calculate a final score for each manual plan to 
simplify our analysis.  
 
2 METHODS AND MATERIALS 
2.1 Patient cases 
With IRB approval, we retrospectively reviewed 21 patients treated for vestibular schwannoma 
using GK radiosurgery with a Leksell GK ICONTM treatment unit at our institution from 2017-2019. 
All patients received a single fraction of 12.5 Gy, prescribed to 50% isodose level to allow higher 
dose within the tumor itself. For each patient, the treatment plan was developed by our GK medical 
physicists using Leksell Gamma Plan (LGP) treatment planning system (Elekta Instrument AB 
Stockholm, Stockholm, Sweden) via manual forward planning, and reviewed and approved by 
radiation oncologists and neurosurgeons for treatment. Several rounds of consultation between 
planners and physicians often occurred during treatment planning to achieve a satisfying plan of 
physicians’ preferred trade-off for each patient. The related plan information of the original manual 
plans for these 22 cases are listed in Table 1 in reverse chronological order.  
 
Table 1. Plan information of the original manual plans for our previous 21 vestibular schwannoma 
cases treated with GK radiosurgery with a Leksell GK ICONTM unit. 
case 
Target 
volume 
(cc) 
Planner Coverage Selectivity 
Gradient 
index 
CI50* 
DBS,0.1cc 
(Gy) 
Dco,mean 
(Gy) 
BOT* 
(min) 
1 0.193 P2 1.00 0.56 3.10 5.54 1.1 4.7 32.55 
2 0.280     P2 1.00 0.58 2.98 5.14 2.4 3.6 27.56 
3 2.273 P2 1.00 0.73 2.65 3.63 11.7 10.7 60.96 
4 1.217 P1 1.00 0.71 2.83 3.99 1.2 0.1 38.22 
5 0.777 P1 1.00 0.69 2.77 4.01 2.8 4.2 60.97 
6 0.303 P2 1.00 0.71 2.97 4.18 2.0 6.9 31.91 
7 0.79 P1 1.00 0.65 2.91 4.48 7.6 8.8 45.95 
8 0.289 P1 1.00 0.56 2.96 5.29 2.5 3.7 41.24 
9 1.4006 P2 1.00 0.63 2.72 4.32 8.7 6.5 51.10 
10 0.093 P2 1.00 0.44 3.48 7.91 1.4 8.1 27.95 
11 0.212 P1 1.00 0.45 3.15 7.00 1.3 4.9 51.78 
12 2.779 P2 1.00 0.81 2.67 3.30 10.0 4.0 42.33 
13 0.379 P2 1.00 0.60 2.86 4.77 2.3 7.5 20.88 
14 2.093 P2 1.00 0.77 2.84 3.69 9.5 6.4 32.60 
15 0.284 P3 0.99 0.51 2.94 5.76 1.3 4.0 22.40 
16 0.283 P1 0.99 0.43 3.03 7.05 1.8 4.0 42.41 
17 0.874 P1 1.00 0.70 2.84 4.06 5.9 4.0 32.13 
18 1.311 P1 1.00 0.78 2.61 3.35 10.1 3.0 34.51 
19 2.13 P3 1.00 0.63 3.27 5.19 4.3 2.4 34.68 
20 0.313 P3 1.00 0.50 2.97 5.94 5.1 4.2 26.19 
21 0.418 P1 1.00 0.65 3.03 4.66 2.5 4.9 36.52 
22 0.415 P1 1.00 0.67 3.17 4.73 5.5 4.0 39.70 
* BOT listed here is the total beam-on time normalized at the initial dose rate 3.534 Gy/min; 
*CI50 denotes conformity index at 50% isodose level as defined in Eq.(4).  
2.2 Study design  
Our MRL inverse planning approach, which will be briefly introduced in subsection 2.4, was used 
to re-plan these previous cases. The same planning guidelines used in our institution to guide manual 
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forward planning for GK radiosurgery of vestibular schwannoma were adopted to guide our re-
planning as well: (1) 100% of prescription dose must be received by at least 99% of the target 
volume, that is, target coverage ≥ 0.99; (2) The maximum dose to 0.1 cc of brainstem must not 
exceed 12 Gy, that is, DBS,0.1cc ≤ 12 Gy; (3) Try to keep the mean dose of the ipsilateral cochlea 
below 4 Gy, that is, Dco,mean ≤ 4 Gy; (4) Try to maximize selectivity and minimize gradient index to 
spare the nearby normal tissues as much as possible. During our inverse planning, we tried to realize 
similar trade-off that was adopted in the original manual plan for fair comparison. The obtained 
plans were expected to be pareto optimal plans or plans close to the pareto surface, and hence were 
considered as “golden” plan to help us to reduce the impact of different patient geometry on plan 
quality evaluation.  
GK plan is usually evaluated in terms of coverage (as defined in Eq.(1)), selectivity (Eq.(2)), 
gradient index (Eq.(3)), OAR dose, and total beam-on time.  
coverage =
𝑇𝑉∩𝑃𝐼𝑉
𝑇𝑉
. (1) 
selectivity =
𝑇𝑉∩𝑃𝐼𝑉
𝑃𝐼𝑉
, (2) 
gradient index =
𝑃𝐼𝑉𝑅𝑥/2
𝑃𝐼𝑉
. (3) 
Here, TV and PIV represent the target volume and the planning isodose volume, respectively. 
𝑃𝐼𝑉𝑅𝑥/2 represents the volume that receives at least half of the prescription dose. Gradient index 
was proposed to compare the dose gradient outside the target for the treatment plans of equal dose 
conformity. It cannot be directly used to compare plans of different conformity level. Hence, instead 
of gradient index, we used conformity index at 50% isodose line (CI50, as defined in Eq.(4)) in this 
study to access the intermediate dose spillage for each treatment plan. 
CI50 =
𝑃𝐼𝑉𝑅𝑥/2
𝑇𝑉
. (4) 
The values of these metric are affected by the specific geometry of each patient as well as the 
trade-offs preferred by the physicians, and therefore cannot be directly compared between different 
cases. Therefore, in this study we calculated the deviation of the original manual plans from the 
golden plans obtained via MRL inverse planning with a similar trade-off. A scoring mechanism was 
also proposed in this study to calculate a single score for each case. Our scoring mechanism has six 
score components, corresponding to coverage, selectivity, CI50, DBS,0.1cc, Dco,mean, and total beam-
on time. Their values are set to be 100 for the golden plan, while the values of these components for 
the manual plan are scored according to the scoring criterion listed in Table 2. The minimum values 
of these score components are set to be 0, and the values are allowed to exceed 100 if a particular 
plan metric of the manual plan is better than that of the golden plan. Specifically, the coverage score, 
denoted as 𝑆𝑐𝑜𝑣𝑒𝑟𝑎𝑔𝑒, is decreased by 10 per 0.01 coverage loss of the manual plan compared to the 
golden plan. To comply with our aforementioned planning guidelines, the value of 𝑆𝑐𝑜𝑣𝑒𝑟𝑎𝑔𝑒 
becomes 0 if the coverage is lower than 0.99. The selectivity score of the manual plan was decreased 
by 3.3 per 0.0275 reduction of selectivity. Similarly, the CI50 score was decreased by 3.3 per 0.09 
increase in CI50, and the BOT score was decreased by 3.3 per 1.8% increase of the total beam-on 
time. These scoring criteria were made based on the observations in our experiments, in which we 
changed the prescribed isodose line of the golden plans to 1% higher without adjusting anything 
else of the plans. It was observed that the coverage deteriorated from 1 to 0.99. At the same time, 
the selectivity was increased by 0.0275 averagely, CI50 was improved by 0.09, and the average 
reduction of BOT was ~1.8%. The resulting increase of DBS,0.1cc and Dco,mean were found to be 
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negligible. The aforementioned scoring criteria were made to yield the same score for two sets of 
the golden plans, considering they are of same quality level but different trade-offs. The scoring 
creteria for DBS,0.1cc and Dco,mean were made emperically based on our institutional planning 
guidelines and our GK planning experiences. Specifically, the score for DBS,0.1cc is decreased by 5.0 
per 1 Gy increase compared to the golden plan, and becomes 0 if DBS,0.1cc exceeds our 12Gy tolerance. 
The score for Dco,mean is decreased by 5.0 per 1 Gy increase when Dco,mean is within our desired 4Gy 
tolerance, and decreased by 10 per 1 Gy increase when Dco,mean exceeds it. This scoring criterion 
does not purport to describe the best clinical plan, but serves here as a relatively objective method 
to quantify the plan quality disparity between the manual plan and the golden plan for each specific 
patient case in this study. The standard deviation of these scores was calculated to assess the plan 
quality variation among all the cases. The plan quality variation was also assessed for each planner.  
 
Table 2. Scoring mechanism proposed in this study to calculate a single score for each case in 
terms of the quality deviation of the original manual plans from the golden plans. 
𝑆𝑐𝑜𝑣𝑒𝑟𝑎𝑔𝑒 = {
100 +
𝑐𝑜𝑣𝑒𝑟𝑎𝑔𝑒𝑚𝑎𝑛𝑢𝑎𝑙 − 𝑐𝑜𝑣𝑒𝑟𝑎𝑔𝑒𝑔𝑜𝑙𝑑𝑒𝑛
0.01
× 10, 𝑖𝑓𝑐𝑜𝑣𝑒𝑟𝑎𝑔𝑒𝑚𝑎𝑛𝑢𝑎𝑙 ≥ 0.99
0, 𝑖𝑓𝑐𝑜𝑣𝑒𝑟𝑎𝑔𝑒𝑚𝑎𝑛𝑢𝑎𝑙 < 0.99
  
𝑆𝑠𝑒𝑙𝑒𝑐𝑡𝑖𝑣𝑖𝑡𝑦 = max (100 +
𝑠𝑒𝑙𝑒𝑐𝑡𝑖𝑣𝑖𝑡𝑦𝑚𝑎𝑛𝑢𝑎𝑙 − 𝑠𝑒𝑙𝑒𝑐𝑡𝑖𝑣𝑖𝑡𝑦𝑔𝑜𝑙𝑑𝑒𝑛
0.0275
× 3.3, 0) 
𝑆𝐶𝐼50 = max (100 −
𝐶𝐼50𝑚𝑎𝑛𝑢𝑎𝑙 − 𝐶𝐼50𝑔𝑜𝑙𝑑𝑒𝑛
0.09
× 3.3, 0) 
𝑆𝐵𝑂𝑇 = max (100 −
(𝐵𝑂𝑇𝑚𝑎𝑛𝑢𝑎𝑙 − 𝐵𝑂𝑇𝑔𝑜𝑙𝑑𝑒𝑛) 𝐵𝑂𝑇𝑔𝑜𝑙𝑑𝑒𝑛⁄
0.018
× 3.3, 0) 
𝑆𝐷𝐵𝑆,0.1𝑐𝑐 = {
100 −
𝐷𝐵𝑆,0.1𝑐𝑐
𝑚𝑎𝑛𝑢𝑎𝑙 −𝐷𝐵𝑆,0.1𝑐𝑐
𝑔𝑜𝑙𝑑𝑒𝑛
1.0 𝐺𝑦
× 5, 𝑖𝑓 𝐷𝐵𝑆,0.1𝑐𝑐
𝑚𝑎𝑛𝑢𝑎𝑙 ≤ 12𝐺𝑦
0, 𝑖𝑓 𝐷𝐵𝑆,0.1𝑐𝑐
𝑚𝑎𝑛𝑢𝑎𝑙 > 12𝐺𝑦 
 
𝑆𝐷𝑐𝑜,𝑚𝑒𝑎𝑛 =
{
 
 
 
 
 
 
 
 100 −
𝐷𝑐𝑜,𝑚𝑒𝑎𝑛
𝑚𝑎𝑛𝑢𝑎𝑙 − 𝐷𝑐𝑜,𝑚𝑒𝑎𝑛
𝑔𝑜𝑙𝑑𝑒𝑛
1.0 𝐺𝑦
× 5, 𝑖𝑓 𝐷𝑐𝑜,𝑚𝑒𝑎𝑛
𝑚𝑎𝑛𝑢𝑎𝑙  𝑎𝑛𝑑 𝐷𝑐𝑜,𝑚𝑒𝑎𝑛
𝑔𝑜𝑙𝑑𝑒𝑛 ≤ 4𝐺𝑦 
100 −
𝐷𝑐𝑜,𝑚𝑒𝑎𝑛
𝑚𝑎𝑛𝑢𝑎𝑙 −𝐷𝑐𝑜,𝑚𝑒𝑎𝑛
𝑔𝑜𝑙𝑑𝑒𝑛
1.0 𝐺𝑦
× 10, 𝑖𝑓 𝐷𝑐𝑜,𝑚𝑒𝑎𝑛
𝑚𝑎𝑛𝑢𝑎𝑙  𝑎𝑛𝑑 𝐷𝑐𝑜,𝑚𝑒𝑎𝑛
𝑔𝑜𝑙𝑑𝑒𝑛 > 4𝐺𝑦 
100 −
𝐷𝑐𝑜,𝑚𝑒𝑎𝑛
𝑚𝑎𝑛𝑢𝑎𝑙 − 4
1.0 𝐺𝑦
× 10 −
4 − 𝐷𝑐𝑜,𝑚𝑒𝑎𝑛
𝑔𝑜𝑙𝑑𝑒𝑛
1.0 𝐺𝑦
× 5, 𝑖𝑓𝐷𝑐𝑜,𝑚𝑒𝑎𝑛
𝑚𝑎𝑛𝑢𝑎𝑙 > 4𝐺𝑦 𝑎𝑛𝑑 𝐷𝑐𝑜,𝑚𝑒𝑎𝑛
𝑔𝑜𝑙𝑑𝑒𝑛 ≤ 4𝐺𝑦
100 −
𝐷𝑐𝑜,𝑚𝑒𝑎𝑛
𝑚𝑎𝑛𝑢𝑎𝑙 − 4
1.0 𝐺𝑦
× 5 −
4 − 𝐷𝑐𝑜,𝑚𝑒𝑎𝑛
𝑔𝑜𝑙𝑑𝑒𝑛
1.0 𝐺𝑦
× 10, 𝑖𝑓𝐷𝑐𝑜,𝑚𝑒𝑎𝑛
𝑚𝑎𝑛𝑢𝑎𝑙 ≤ 4𝐺𝑦 𝑎𝑛𝑑 𝐷𝑐𝑜,𝑚𝑒𝑎𝑛
𝑔𝑜𝑙𝑑𝑒𝑛 > 4𝐺𝑦 
 
𝑆𝑡𝑜𝑡𝑎𝑙 = (𝑆𝑐𝑜𝑣𝑒𝑟𝑎𝑔𝑒 + 𝑆𝑠𝑒𝑙𝑒𝑐𝑡𝑖𝑣𝑖𝑡𝑦 + 𝑆𝐶𝐼50 + 𝑆𝐵𝑂𝑇 + 𝑆𝐷𝐵𝑆,0.1𝑐𝑐 + 𝑆𝐷𝑐𝑜,𝑚𝑒𝑎𝑛)/6 
 
2.3 MRL inverse planning 
MRL inverse planning approach is an iterative approach that we recently developed to solve the 
intractable large-scale GK global optimization problem to find a global optimal plan or an 
approximate global optimal plan19. In this approach, several rounds of optimization are performed 
with a progressively increased resolution used for isocenter candidates. Specifically, at the 
beginning a coarse 3D grid is employed to discretize all the locations within the target into grid 
points and used as initial isocenter candidates. A convex optimization problem was solved to 
optimize the beam-on time for each sector of each available collimator size at each isocenter 
candidate. The optimal isocenters are the isocenter candidates that obtain non-zero beam-on time 
during the optimization. In this way, the isocenter location is actually optimized along with the 
collimator sizes and beam durations, unlike the other sequential inverse planning algorithms which 
pre-determine the isocenters based on some geometric methods and only optimize the beam shape 
and duration at these predetermined isocenters. At the next round of optimization, these optimal 
isocenters determined at the previous resolution level are used as new isocenter candidates. A finer 
grid resolution is also used to add the neighboring grid points of these optimal isocenters into the 
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isocenter candidate set to fine tune the isocenter locations and search for a better solution if it exists. 
The objective function that is used at each round of optimization but with different sets of isocenter 
candidates is formulated as  
            minimize𝑡  
𝜔𝑇𝐻
𝑁𝑇
∑ max(𝐷𝑖−𝐷𝑇𝐻 , 0)
𝑖∈𝐼𝑇
+
𝜔𝑇𝐿
𝑁𝑇
∑ max(𝐷𝑇𝐿 − 𝐷𝑖 , 0)
𝑖∈𝐼𝑇
+
𝜔𝐼𝑆
𝑁𝐼𝑆
∑ max(𝐷𝑖 − 𝐷𝐼𝑆, 0) +
𝜔𝑂𝑆
𝑁𝑂𝑆
∑ max(𝐷𝑖 − 𝐷𝑂𝑆 , 0)
𝑖∈𝐼𝑂𝑆𝑖∈𝐼𝐼𝑆
 
                              +
𝜔𝐵𝑆
𝑁𝐵𝑆
∑ 𝑚𝑎𝑥(𝐷𝑖 − 𝐷𝐵𝑆)
𝑖∈𝐵𝑆
+
𝜔𝑐𝑜
𝑁𝑐𝑜
∑ (𝐷𝑖 − 𝐷𝑐𝑜)
𝑖∈𝐼𝑐𝑜
+ 𝜔𝐵𝑂𝑇∑ max𝑚=1,2,..,8 (∑ 𝑡(𝑐,𝑚, 𝑛)
3
𝑐=1
)
𝑁
𝑛=1
, 
          subject 𝑡𝑜 𝑡 ≥ 0. 
(5) 
Here, 𝑡 is the beam-on time to be optimized for each sector candidate, that is, each physical sector 
(𝑚 = 1,2, ,8) with a collimator size (𝑐 = 1, 2, 3 corresponding to 4 mm, 8 mm and 16 mm 
collimators) at an isocenter candidate (𝑛 =1,2, , 𝑁𝑖𝑠𝑜𝑐). Seven planning objectives are used in this 
objective function, corresponding to target maximum and minimum doses, maximum doses 
received by the inner and outer shells of the target, brainstem maximum dose, mean dose of the 
ipsilateral cochlea and total beam-on time, respectively. 𝜔𝑋  denotes the user-specified priority for 
the corresponding objective, which were manually adjusted in our study to achieve the similar trade-
offs adopted in the original manual plans. After the optimization, sectors with non-zero beam-on 
time at a same isocenter are grouped into composite shots for delivery via shot sequencing. In this 
study, the obtained golden plans were put back into the LGP system for final dose calculation.  
 
3 RESULTS 
The plan metrics of the golden plans obtained via MRL inverse planning are listed in Table 3, and 
compared to the corresponding values of the forward planned manual plans originally shown in 
Table 2. The difference of these metric values between the manual plans and the golden plans are 
calculated and listed in Table 4. The scores of the manual plans in terms of their deviation from the 
corresponding golden plan were calculated using our scoring mechanism and listed in Table 5. These 
scores have been reviewed by our physicians and considered to be reasonable values.  
 
Table 3. Plan metrics of the original manual plans for our previous cases, and those of the golden plans obtained by MRL 
inverse planning for each case for plan quality evaluation purpose.  
case 
Original manual plans Golden plans obtained by MRL inverse planning 
Coverage Selectivity 
Gradient 
index 
CI50 
DBS,0.1cc 
(Gy) 
Dco,mean 
(Gy) 
BOT* 
(min) 
Coverage Selectivity 
Gradient 
index 
CI50 
DBS,0.1cc 
(Gy) 
Dco,mean 
(Gy) 
BOT* 
(min) 
1 1.00 0.56 3.10 5.54 1.1 4.7 32.55 1.00 0.65 3.61 5.55 1.1 4.7 27.66 
2 1.00 0.58 2.98 5.14 2.4 3.6 27.56 1.00 0.74 3.26 4.41 2.1 3.8 26.69 
3 1.00 0.73 2.65 3.63 11.7 10.7 60.96 1.00 0.76 2.79 3.67 11.6 9.9 41.98 
4 1.00 0.71 2.83 3.99 1.2 0.1 38.22 1.00 0.79 3.12 3.95 1.3 0.1 27.05 
5 1.00 0.69 2.77 4.01 2.8 4.2 60.97 1.00 0.82 3.02 3.68 2.9 3.6 41.29 
6 1.00 0.71 2.97 4.18 2.0 6.9 31.91 1.00 0.73 2.83 3.88 2.3 6.6 34.23 
7 1.00 0.65 2.91 4.48 7.6 8.8 45.95 1.00 0.71 2.80 3.94 7.6 8.0 43.02 
8 1.00 0.56 2.96 5.29 2.5 3.7 41.24 1.00 0.69 3.48 5.04 3.4 3.6 29.75 
9 1.00 0.63 2.72 4.32 8.7 6.5 51.10 1.00 0.71 2.75 3.87 8.1 5.9 50.50 
10 1.00 0.44 3.48 7.91 1.4 8.1 27.95 1.00 0.55 3.32 6.04 1.2 8.3 27.47 
11 1.00 0.45 3.15 7.00 1.3 4.9 51.78 1.00 0.73 3.07 4.21 1.2 4.6 45.08 
12 1.00 0.81 2.67 3.30 10.0 4.0 42.33 1.00 0.87 2.71 3.11 10.2 3.0 37.06 
13 1.00 0.60 2.86 4.77 2.3 7.5 20.88 1.00 0.71 3.20 4.51 2.2 7.0 20.88 
14 1.00 0.77 2.84 3.69 9.5 6.4 32.60 1.00 0.76 2.67 3.51 10.7 5.5 32.98 
15 0.99 0.51 2.94 5.76 1.3 4.0 22.40 0.99 0.70 3.71 5.30 1.8 3.4 23.74 
16 0.99 0.43 3.03 7.05 1.8 4.0 42.41 1.00 0.69 3.35 4.86 1.9 3.6 36.49 
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17 1.00 0.70 2.84 4.06 5.9 4.0 32.13 1.00 0.77 3.29 4.27 5.7 3.8 30.44 
18 1.00 0.78 2.61 3.35 10.1 3.0 34.51 1.00 0.87 2.92 3.36 9.9 2.3 32.78 
19 1.00 0.63 3.27 5.19 4.3 2.4 34.68 1.00 0.67 2.91 4.34 4.5 1.5 35.21 
20 1.00 0.50 2.97 5.94 5.1 4.2 26.19 1.00 0.56 2.87 5.13 4.3 3.7 25.90 
21 1.00 0.65 3.03 4.66 2.5 4.9 36.52 1.00 0.65 2.79 4.29 2.3 4.7 36.03 
22 1.00 0.67 3.17 4.73 5.5 4.0 39.70 1.00 0.67 3.05 4.55 6.8 3.5 38.71 
* BOT listed here is the total beam-on time normalized at the initial dose rate 3.534 Gy/min 
The best plan quality that can be achieved for each patient depends on their specific geometry, 
while different trade-offs adopted in planning result in different values of plan metrics. Therefore, 
it is difficult to quantify the plan quality for each case and the quality variation among different 
patients. For instance, case 4 and case 6 have different geometries in terms of target volume, shape, 
and the distance between target to brainstem and cochlea, as shown in the third and fifth columns in 
Fig. 1. The original manual plans for case 4 and case 6 achieved the same target coverage (1.0) and 
selectivity (0.71), and similar CI50 (3.99 and 4.18, respectively). The manual plan of case 6 has 
slightly higher brainstem 0.1cc dose than that of case 4 (2.0 Gy vs. 1.2 Gy) and much higher cochlea 
mean dose (6.9 Gy vs. 0.1 Gy), which is likely due to the relatively smaller distance between the 
target target and these two OARs. The BOT of the manual plan for case 6 is shorter than that of case 
4 (31.91 min vs. 38.22 min), which may be due to its relatively smaller target volume (0.303 cc vs. 
1.217 cc) and/or the different trade-off between cochlea mean dose and BOT adopted for this case. 
Without clearly knowing how much the different geometry affect each metric given a specified 
trade-off, it is difficult to judge whether the plan quality of the manual plan of case 6 is comparable, 
better, or worse than that of case 4 when comparing these two plans directly, although both plans 
have been reviewed and approved by physicians for treatment. In contrast, when comparing the 
manual plan with the corresponding golden plan obtained with similar trade-off, the distance of the 
manual plan from the pareto surface can be quantified to assess its quality level. For case 4, with 
the same coverage and similar CI50 and OAR doses being obtained, the golden plan has higher 
selectivity (0.79 vs. 0.71) and much shorter BOT (27.05 min vs. 38.22 min) compared to the manual 
plan. For case 6, the metrics of its golden plan are close to those of the manual plan, i.e., same 
coverage, slightly higher selectivity (0.73 vs. 0.71) and lower CI50 (3.88 vs. 4.18), 0.3 Gy higher in 
brainstem dose and 0.3 Gy lower in cochlea dose, and 2.32 min longer of BOT. It can be concluded 
that the distance from the manual plan to the pareto surface is larger in case 4 than that in case 6, 
hence the manual plan of case 4 is of worse quality than case 6, although their plan metrics are of 
comparable values. This conclusion is also reflected via the final scores. The manual plan of case 4 
got a final score of 85.5 mainly due to the low BOT score (23.5), while the manual plan of case 6 
got a final score of 99.6.  
 
Table 4. Deviations of the manual plans from the golden plans  
case ∆𝑐𝑜𝑣𝑒𝑟𝑎𝑔𝑒 ∆𝑠𝑒𝑙𝑒𝑐𝑡𝑖𝑣𝑖𝑡𝑦 ∆𝐶𝐼50 
∆𝐷𝐵𝑆,0.01𝑐𝑐 
(Gy) 
∆𝐷𝑐𝑜,𝑚𝑒𝑎𝑛 
(Gy) 
∆𝐵𝑂𝑇 
(min) 
∆𝐵𝑂𝑇 
(%) 
1 0 -0.09 -0.01 0 0 4.89 17.68 
2 0 -0.16 0.73 0.30 -0.20 0.87 3.26 
3 0 -0.03 -0.04 0.10 0.80 18.98 45.21 
4 0 -0.08 0.04 -0.10 0 11.17 41.29 
5 0 -0.13 0.33 -0.10 0.60 19.68 47.66 
6 0 -0.02 0.30 -0.30 0.30 -2.32 -6.78 
7 0 -0.06 0.54 0 0.80 2.93 6.81 
8 0 -0.13 0.25 -0.90 0.10 11.49 38.62 
9 0 -0.08 0.45 0.60 0.60 0.60 1.19 
10 0 -0.11 1.87 0.20 -0.20 0.48 1.75 
11 0 -0.28 2.79 0.10 0.30 6.70 14.86 
12 0 -0.06 0.19 -0.20 1.00 5.27 14.22 
13 0 -0.11 0.26 0.10 0.50 0.00 0.00 
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14 0 0.01 0.18 -1.20 0.90 -0.38 -1.15 
15 0 -0.19 0.46 -0.50 0.60 -1.34 -5.64 
16 -0.01 -0.26 2.19 -0.10 0.40 5.92 16.22 
17 0 -0.07 -0.21 0.20 0.20 1.69 5.55 
18 0 -0.09 -0.01 0.20 0.70 1.73 5.28 
19 0 -0.04 0.85 -0.20 0.90 -0.53 -1.51 
20 0 -0.06 0.81 0.80 0.50 0.29 1.12 
21 0 0 0.37 0.20 0.20 0.49 1.36 
22 0 0 0.18 -1.30 0.50 0.99 2.56 
mean -0.0004 -0.09 0.53 -0.10 0.41 3.90 10.88 
SD 0.002 0.07 0.77 0.50 0.36 6.07 16.51 
 
It can be observed from Table 4 that the deviation of the original manual plan from the golden 
plan varies for difference cases. Specifically, the deviation ranges from -0.01 to 0 in coverage, -0.28 
to 0.01 in selectivity, -0.21 to 2.79 in CI50, -1.3 Gy to 0.8 Gy in brainstem 0.1cc dose, -0.2 Gy to 
1.0 Gy in cochlea mean dose, and -2.32 min to 19.68 min in BOT (which is -6.78% to 47.66% of 
BOT of the golden plans). Averaged over all the cases, the mean deviation ± standard deviation is -
0.0004 ± 0.002 in coverage, -0.09 ± 0.07 in selectivity, 0.53 ± 0.77 in CI50, -0.1 ± 0.5 Gy in 
brainstem dose, 0.41 ± 0.36 Gy in cochlea dose, and 3.90 ± 6.07 min in BOT (i.e., 10.88% ± 16.51% 
of BOT of the golden plans). Correspondingly, the final scores of these manual plans range from 
72.5 to 99.6, with two cases having a score lower than 75, three cases scoring between 80 and 85, 
two case between 85 and 90, eight cases between 90 and 95, and seven cases higher than 95. The 
mean score of these manual plans is 90.6 ± 7.7.  
The two cases of the lowest scores (i.e., cases 11 and 16 with a score of 72.5 and 74.3, 
respectively) and the two cases of the highest scores (i.e., cases 6 and 14 with a score of 99.6 and 
98.9, respectively) are shown in Figure 1. It can be seen that the manual plans of cases 11 and 16 
have much worse dose conformity than their golden plans, while the manual plans of cases 6 and 
14 have comparable dose conformity relative to their golden plans. In cases 10 and 15, the BOT of 
the manual plans are 14.86% and 15.22% longer than that of their golden plans. In contrast, the BOT 
of the manual plans in cases 6 and 14 are 6.78% and 5.64% shorter than their golden plans. 
 
Table 5. Scores calculated for the manual plans using our scoring mechanism 
case planner 𝑆𝑐𝑜𝑣𝑒𝑟𝑎𝑔𝑒 𝑆𝑠𝑒𝑙𝑒𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝑆𝐶𝐼50 𝑆𝐷𝐵𝑆,0.01𝑐𝑐 𝑆𝐷𝑐𝑜,𝑚𝑒𝑎𝑛 𝑆𝐵𝑂𝑇   𝑆𝑡𝑜𝑡𝑎𝑙 
1 P2 100 89.1 100.4 100 100 67.3    92.8 
2 P2 100 80.6 73.0 98.5 101 94.0    91.2 
3 P2 100 96.4 101.5 99.5 92.0 16.3    84.3 
4 P1 100 90.3 98.5 100.5 100.0 23.5    85.5 
5 P1 100 84.2 87.8 100.5 96.0 11.7    80.0 
6 P2 100 97.6 88.9 101.5 97.0 112.6    99.6 
7 P1 100 92.7 80.0 100 92.0 87.4    92.0 
8 P1 100 84.2 90.7 104.5 99.5 28.5    84.6 
9 P2 100 90.3 83.3 97.0 94.0 97.8    93.7 
10 P2 100 86.7 30.7 99.0 102.0 96.8    85.9 
11 P1 100 66.1 0 99.5 97.0 72.5    72.5 
12 P2 100 92.7 93.0 101.0 95.0 73.7    92.6 
13 P2 100 86.7 90.4 99.5 95.0 100    95.3 
14 P2 100 101.2 93.3 106.0 91.0 102.1    98.9 
15 P3 100 77.0 83.0 102.5 97.0 110.5    95.0 
16 P1 90 68.5 18.9 100.5 98.0 70.0    74.3 
17 P1 100 91.5 107.8 99.0 99.0 89.7    97.8 
18 P1 100 89.1 100.4 99.0 96.5 90.2    95.9 
19 P3 100 95.2 68.5 101.0 95.5 102.8    93.8 
20 P3 100 92.7 70.0 96.0 96.5 97.9    92.2 
21 P1 100 100 86.3 99.0     98.0 97.5    96.8 
22 P1 100 100 93.3 106.5 97.5 95.3    98.8 
mean 99.5    88.8 79.1     100.5 96.8     79.0    90.6   
10 
 
 
SD 2.1 9.3 27.8 2.6 2.9 31.0   7.7 
 
 
 
Figure 1. Isodose lines of the manual and golden plans for cases 11, 16, 4, 14, 6. They are arranged from 
left to right in ascending order of their manual plan score. Cases 11 and 16 have the lowest scores, and cases 
14 and 6 that have the highest scores. The top row shows a slice of MR image for each case, overlaid with 
contours of target (red), brainstem (orange) and cochlea (blue). Cochlea is relatively far away from target in 
case 4 and is not shown. The bottom row shows the zoomed-in target region, with the isodose lines of the 
original manual plan (solid line) and the golden plan (dashed line). The isodose lines of prescription dose 
are shown in yellow and isodose lines of half of the prescription dose are shown in green.   
 
We have also investigated plan quality variability for each planner. Large variability was found 
for planner P1, whose plan scores range from 72.5 (the lowest score in our study) to 98.8 (the second 
highest score). The average score for P1 is 87.8 with a standard deviation of 9.9. The plans generated 
by planner P2 are scored from 84.3 to 99.6, the mean score is 92.7 ± 5.2. The plans generated by 
planner P3 are scored from 92.2 to 95.0. Although he didn’t produce a plan with a score higher than 
95, he has the highest average score (93.7) and smallest standard deviation (1.4) among the three 
planners. These results not only demonstrate the inter-planner variability in GK planning, but also 
the intra-planner variability.  
 
4. DISCUSSIONS AND CONCLUSIONS 
There have been a few metrics proposed to evaluate a GK plan, such as coverage, selectivity and 
gradient index. However, an equivalent value of these metrics does not necessarily equate to the 
same quality level for different geometries, which is well demonstrated by the example of case 4 
and case 6 shown in section 3. The manual plans of these two cases achieved the same coverage and 
selectivity, and similar gradient index. The relatively higher OAR doses and shorter BOT in case 6 
seem to be reasonable due to its smaller distance between the target and the OARs and its smaller 
target volume. With these metric values, one may conclude that these two plans are of comparable 
quality level. In fact, the target of case 4 has a more spherical shape with a higher convexity than 
that of case 6. According to the nature of GK planning, case 4 is therefore less challenging for 
planning and one should expect better metric values than case 6. This impact of various patient 
geometries on GK planning needs to be considered in plan quality evaluation. Another confounding 
factor on plan quality evaluation is the different trade-offs adopted during treatment planning, which 
further challenges the plan evaluation and comparison among different cases. Therefore, in order to 
reduce these interferences on GK planning to objectively assess the plan quality and quality 
variation among different cases, in this study we assessed the plan quality for each specific case 
based on the deviation of the original manual plan from its corresponding golden plan. The golden 
plan was obtained by employing our recently developed MRL inverse planning approach. Its ability 
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to yield a pareto optimal plan or a plan close to the pareto surface has been validated in our previous 
study19. Hence, we consider these golden plans generated by our computational optimization 
algorithms to be of a consistently high quality level.  
To simplify our quality assessment, a scoring mechanism was proposed to calculate a single 
score for each case based on the quality disparity between the manual plan and the corresponding 
golden plan. This scoring mechanism was designed empirically, based on our observations and 
experiences during GK planning. We have found that although the exact score values depend on the 
values of the parameters involved in the scoring mechanism, the relative ranking of two plans at two 
different quality levels are insensitive to the parameters. It is critical to emphasize that the purpose 
of our scoring criterion is not to describe the best clinical plan, but to serve as a consistent, 
reasonable, and more importantly, relatively objective criterion to quantify the disparity between the 
manual plan and the golden plan for each case in our retrospective study.  
There are two limitations of this retrospective study. One is the small amount of the patient 
cases investigated in this study, which is limited by the relatively low incidence of vestibular 
schwannoma compared to other brain tumors in general as well as the patient population in our 
institution. Another limitation is the considerable amount of human intervention involved. Since the 
golden plans were generated using our own planning algorithm outside of the commercial GK 
planning system LGP, these plans were put back to LGP for final dose calculation to ensure fair 
comparison. However, the current LGP system does not provide a data interface to import the shot 
locations, shapes and relative weights. The shot information must be manually entered into the 
system, which substantially increases the workload and is another limitation to the number of patient 
cases in our study. This issue can only be resolved by collaborating with Elekta to build a data 
interface for plans generated by other algorithms or systems, which will not only facilitate similar 
studies to this one, but also promote the development of external novel GK planning algorithms.  
Although we only investigated 22 vestibular schwannoma cases, large variation of plan quality 
was observed among these cases. Variability was observed in both inter-planner and intra-planner 
treatment plan quality. This deserves high attention and merits further discussion and investigation 
on how to reduce the variation in GK treatment plan quality. Without knowing the best achievable 
plan quality for a given patient case, when to stop fine-tuning the plan and searching for potentially 
better quality can be a very subjective decision, relying on the experience and patience level of the 
planner at that moment. It also depends on the available time that can be devoted to that particular 
case. There are two potential ways to reduce the quality variation in GK planning. One is to develop 
a plan quality control system which can predict the best achievable plan quality for new patient 
cases based on their geometry. Machine learning or deep learning techniques can be employed to 
learn some prior knowledge from our previous cases to predict the plan quality for new cases20-23. 
Another way to reduce quality variation is to promote the development and clinical application of 
advanced planning algorithms for GK radiosurgery. Although there is a sequential inverse planning 
algorithm provided in the LGP system24, it only optimizes the shots’ sizes and durations at the 
predetermined isocenters and tends to be trapped in a local minimum, and thus can only provide a 
first approximation dose plan. Recently, a few inverse planning algorithms, including our MRL 
algorithm, have been developed that are able to optimize the isocenter locations and shots shapes 
and durations simultaneously7,8,25,26. However, an open data interface is much needed to facilitate 
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the clinical validation and application of these external planning algorithms. Artificial intelligence 
may also be used to build and train a virtual GK planner with human-level intelligence27,28.  
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